A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection
Clinical trial NCT00000669 · COMPLETED
Trial details
- NCT number
- NCT00000669
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.